ClinicalTrials.gov
public full text
Public Domain
Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
Our overall aim is to determine if the administration of guanfacine in combination with aripiprazole, olanzapine, quetiapine, and/or risperidone is significantly more effective than any of those medications alone in treating some of the cognitive impairment in schizophrenia.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study#850873
- Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia#1151040
- PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia#861423
- Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients#844673
- The Effect of Guanfacine on Delirium in Critically Ill Patients#906969
Record · ID 1007554
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive